Marcia Belvin - Mar 18, 2025 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
SVP, Chief Scientific Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Marcia Belvin
Stock symbol
CTMX
Transactions as of
Mar 18, 2025
Transactions value $
-$11,688
Form type
4
Date filed
3/20/2025, 04:31 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$11.7K -19.5K -7.28% $0.60 249K Mar 18, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 Includes 158,958 RSUs.